Early response of retinal angiomatous proliferation treated with intravitreal pegaptanib: A retrospective review

Eye

Volumn 23, Issue 3, 2009, Pages 530-535

  Mahmood, S ^a   Kumar, N ^a   Lenfestey, P M ^a   Murjaneh, S ^a   Heimann, H ^a   Harding, S P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Intravitreal; Macugen; Pegaptanib; Retinal angiomatous proliferation

Indexed keywords

PEGAPTANIB; TRIAMCINOLONE; ANGIOGENESIS INHIBITOR; APTAMER; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINAL ANGIOMATOUS PROLIFERATION; TREATMENT RESPONSE; VISUAL ACUITY; ANGIOMATOSIS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG SCREENING; INTRAOCULAR DRUG ADMINISTRATION; MACULAR DEGENERATION; MIDDLE AGED; PATHOPHYSIOLOGY; RETINAL DISEASES; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANGIOMATOSIS; APTAMERS, NUCLEOTIDE; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL DISEASES; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 62549164692     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.101     Document Type: Article

References (23)

1. Slakter JS, Yannuzzi LA, Schneider U, Sorenson JA, Ciardella A, Guyer DR et al Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2000; 107(4): 742-753; discussion 753-4.
2. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J et al Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21(5): 416-434.
3. Krebs I, Stolba U, Glittenberg C, Seyeddain O, Benesch T, Binder S. Prognosis of untreated occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2007; 245(3): 376-384.
4. Gross NE, Aizman A, Brucker A, Klancnik Jr JM, Yannuzzi LA. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 2005; 25(6): 713-718.
5. Johnson TM, Glaser BM. Focal laser ablation of retinal angiomatous proliferation. Retina 2006; 26(7): 765-772. erratum appears in Retina 2007; (2):263.
6. Slakter JS, Yannuzzi LA, Schneider U, Sorenson JA, Ciardella A, Guyer DR et al Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2000; 107(4): 742-753.
7. Borrillo JL, Sivalingam A, Martidis A, Federman JL. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 2003; 121(4): 558-561.
8. Shiragami C, Iida T, Nagayama D, Baba T, Shiraga F. Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 2007; 27(2): 198-203.
9. Klais CM, Eandi CM, Ober MD, Sorenson JA, Sadeghi SN, Freund KB et al Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study. Retina 2006; 26(7): 773-779.
10. Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 2004; 138(6): 1077-1079.
11. Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA et al Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006; 124(4): 487-492.
12. van de Moere A, Kak R, Sandhu SS, Talks SJ. Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 2007; 143(4): 701-704.
13. Krebs I, Binder S, Stolba U. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006; 244(7): 863-867. e-pub ahead of print 6 December 2005.
14. Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004; 138(5): 740-743.
15. Jonas JB, Sauder G, Budde WM, Spandau UH, Kamppeter BA, Harder B. Triamcinolone acetonide-induced ocular hypertension. J Ocul Pharmacol Ther 2006; 22(4): 247-250.
16. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR, for the VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for Neovascular Age-Related Macular Degeneration. N Engl J Med 2004; 351: 2805-2816.
17. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al, ANCHOR Study Group. Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1432-1444.
18. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1419-1431.
19. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363-372.
20. Spaide RF, Laud K, Fine HF, Klancnik Jr JM, Meyerle CB, Yannuzzi LA et al Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006; 26: 383-390.
21. Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS et al Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007; 27(4): 451-457.
22. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007; 245(11): 1597-1602.
23. Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I, Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005; 123(12): 1644-1650.